Tag: Abraxis Bioscience

Indian Patent office rejects Patent claim over Abraxane

In a major setback, the Indian Patent Office denied a patent to an anti-cancer drug Abraxane manufactured by US-Based Abraxis BioSciences. Here we will discuss the decision given by IPO at the backdrop of the arguments advanced by the respective parties. The copy of the decision made by the Controller General of Patents can be … Continue reading Indian Patent office rejects Patent claim over Abraxane

Read more »